The purpose of the PLCO Trial is to determine if screening for prostate, lung colorectal, and ovarian cancers aids in reducing mortality from these diseases. Men and women 55-74 years old were recruited into the study at 10 sites nationwide. Recruitment was completed in 2001 with 154,938 participants recruited into the study. Each participant will be followed for at least 13 years from randomization. During this next approval period PLCO participants will be followed for cancer and vital status ascertainment. Participants will complete an Annual Study Update (ASU) questionnaire, Health Screening Questionnaire (HSQ), and a Prostate Cancer Recurrence Questionnaire (PCRQ). If cancer is reported, diagnosis and treatment information is collected through abstracting medical records. Deaths are ascertained through the annual follow-up process.
Annualized burden is estimated at 11,401 hours per year for the proposed 3 years of data collection (Years 16, 17, and 18) of the PLCO trial. The annualized burden hours for the previous cycle (Years 13-15) was 23,086 hours. Estimated burden hours for this OMB cycle have dropped considerably this year because we are experiencing more deaths with study participants as they age. Additionally, a new instrument has been added, the Prostate Cancer Recurrence Questions (PCRQ) to complete information on prostate cancer in selected PLCO trial participants. The PCRQ will be administered twice: once at 5-years post-diagnosis and again at 10-years post-diagnosis.
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.